NCT03989973

Brief Summary

The purpose of this retrospective study was to investigate the diagnostic performance of 2D-SWE for predicting the presence of esophageal varices and high-risk varices in patients with liver cirrhosis.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
500

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Sep 2016

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2016

Completed
2.8 years until next milestone

First Submitted

Initial submission to the registry

June 16, 2019

Completed
2 days until next milestone

First Posted

Study publicly available on registry

June 18, 2019

Completed
3.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2022

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2023

Completed
Last Updated

June 18, 2019

Status Verified

June 1, 2019

Enrollment Period

6 years

First QC Date

June 16, 2019

Last Update Submit

June 17, 2019

Conditions

Keywords

Liver cirrhosisEsophageal VaricesLiver StiffnessSpleen Stiffness

Outcome Measures

Primary Outcomes (2)

  • Liver Stiffness

    Liver stiffness assessed by 2D-SWE

    1 day (At 2D-SWE scanning time)

  • Varices stage

    Gastroscopy was used to assess varices stage

    1 day (At gastroscopy performed time)

Study Arms (1)

Cirrhosis patients

Patients were diagnosed by liver biopsy, CT or ultrasound

Diagnostic Test: Gastroscopy

Interventions

GastroscopyDIAGNOSTIC_TEST

Gastroscopy

Cirrhosis patients

Eligibility Criteria

Age16 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

compensated cirrhosis

You may qualify if:

  • Cirrhosis were diagnosed by liver biopsy, CT and ultrasound before enrolled
  • Age was 16-80

You may not qualify if:

  • With bleeding history
  • With EVL history, BRTO or TIPS history
  • With NSBB history
  • With ascites
  • With splenectomy or splenic embolism, history
  • With liver cancer

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

West China Hospital of Sichuan Univerisity

Chengdu, Sichuan, China

RECRUITING

MeSH Terms

Conditions

Liver CirrhosisEsophageal and Gastric Varices

Interventions

Gastroscopy

Condition Hierarchy (Ancestors)

Liver DiseasesDigestive System DiseasesFibrosisPathologic ProcessesPathological Conditions, Signs and SymptomsEsophageal DiseasesGastrointestinal DiseasesHypertension, Portal

Intervention Hierarchy (Ancestors)

Endoscopy, GastrointestinalEndoscopy, Digestive SystemDiagnostic Techniques, Digestive SystemDiagnostic Techniques and ProceduresDiagnosisEndoscopyDiagnostic Techniques, SurgicalDigestive System Surgical ProceduresSurgical Procedures, OperativeMinimally Invasive Surgical Procedures

Study Officials

  • Xuefeng Luo

    West China Hospital of Sicuan Univerisity

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
3 Years
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

June 16, 2019

First Posted

June 18, 2019

Study Start

September 1, 2016

Primary Completion

September 1, 2022

Study Completion

September 1, 2023

Last Updated

June 18, 2019

Record last verified: 2019-06

Data Sharing

IPD Sharing
Will not share

Locations